Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools
- 24 March 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (9) , 2859-2878
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- [Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imagingBioorganic & Medicinal Chemistry Letters, 2010
- Illuminating the life of GPCRsCell Communication and Signaling, 2009
- Determination of Affinity and Activity of Ligands at the Human Neuropeptide Y Y 4 Receptor by Flow Cytometry and Aequorin LuminescenceJournal of Receptors and Signal Transduction, 2007
- Determination of picomolar concentrations of proteins using novel amino reactive chameleon labels and capillary electrophoresis laser-induced fluorescence detectionElectrophoresis, 2005
- A New Polymer-Supported Reagent for the Synthesis of β-Lactams in SolutionThe Journal of Organic Chemistry, 2004
- COMPUTER AIDED BENZOTHIAZOLE DERIVATIVES. SYNTHESIS, STRUCTURE AND BIOLOGICAL STUDY OF NEW PUSH-PULL CONJUGATED BENZOTHIAZOLIUM SALTSHeterocyclic Communications, 2001
- Cloning and functional expression of the hNPY Y5receptor in human endometrial cancer (HEC-1B) cellsCanadian Journal of Physiology and Pharmacology, 2000
- Synthetic model of a bleomycin metal complexJournal of the Chemical Society, Chemical Communications, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Studies in the Imidazolone Series. The Synthesis of a Lower and a Higher Homolog of Desthiobiotin and of Related Substances1Journal of the American Chemical Society, 1946